[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL131254A0 - 2,3-Dihydrofuro ¬3,2-b¾ pyridin preparation and application thereof in therapy - Google Patents

2,3-Dihydrofuro ¬3,2-b¾ pyridin preparation and application thereof in therapy

Info

Publication number
IL131254A0
IL131254A0 IL13125498A IL13125498A IL131254A0 IL 131254 A0 IL131254 A0 IL 131254A0 IL 13125498 A IL13125498 A IL 13125498A IL 13125498 A IL13125498 A IL 13125498A IL 131254 A0 IL131254 A0 IL 131254A0
Authority
IL
Israel
Prior art keywords
dihydrofuro
therapy
application
pyridin preparation
pyridin
Prior art date
Application number
IL13125498A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of IL131254A0 publication Critical patent/IL131254A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL13125498A 1997-03-20 1998-03-17 2,3-Dihydrofuro ¬3,2-b¾ pyridin preparation and application thereof in therapy IL131254A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9703395A FR2761072B1 (fr) 1997-03-20 1997-03-20 Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique
PCT/FR1998/000531 WO1998042713A1 (fr) 1997-03-20 1998-03-17 DERIVES DE 2,3-DIHYDROFURO[3,2-b]PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
IL131254A0 true IL131254A0 (en) 2001-01-28

Family

ID=9505006

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13125498A IL131254A0 (en) 1997-03-20 1998-03-17 2,3-Dihydrofuro ¬3,2-b¾ pyridin preparation and application thereof in therapy

Country Status (22)

Country Link
US (1) US6143761A (hu)
EP (1) EP0971929A1 (hu)
JP (1) JP2001518099A (hu)
KR (1) KR20000076282A (hu)
CN (1) CN1251105A (hu)
AR (1) AR012097A1 (hu)
AU (1) AU6924298A (hu)
BG (1) BG103684A (hu)
BR (1) BR9808346A (hu)
CA (1) CA2282320A1 (hu)
CO (1) CO4940417A1 (hu)
EE (1) EE9900414A (hu)
FR (1) FR2761072B1 (hu)
HU (1) HUP0002335A3 (hu)
IL (1) IL131254A0 (hu)
NO (1) NO994527L (hu)
NZ (1) NZ337566A (hu)
PL (1) PL335759A1 (hu)
SK (1) SK127699A3 (hu)
TR (1) TR199902115T2 (hu)
WO (1) WO1998042713A1 (hu)
ZA (1) ZA982365B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790474B1 (fr) * 1999-03-05 2001-04-06 Synthelabo Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
SE9902267D0 (sv) * 1999-06-16 1999-06-16 Astra Ab New compounds
JP2005104838A (ja) * 2003-01-09 2005-04-21 Tanabe Seiyaku Co Ltd 縮合フラン化合物
WO2006031856A2 (en) 2004-09-13 2006-03-23 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
CN101772346B (zh) 2007-04-02 2014-05-07 帕金森氏病研究院 用于降低治疗副作用的方法和组合物
EP3250258A4 (en) 2015-01-28 2018-09-05 Chrono Therapeutics, Inc. Drug delivery methods and systems
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
AU2018205529B2 (en) 2017-01-06 2023-08-10 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
CA3101966A1 (en) 2018-05-29 2019-12-05 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE200084T1 (de) * 1995-07-28 2001-04-15 Abbott Lab Furo-, thieno- und pyrrolopyridine und verwandte pyrinidin-, pyridazin- und triazinverbindungen verwendbar zur kontrolle von chemische synaptische übertragung

Also Published As

Publication number Publication date
US6143761A (en) 2000-11-07
PL335759A1 (en) 2000-05-22
TR199902115T2 (xx) 2000-01-21
AR012097A1 (es) 2000-09-27
EE9900414A (et) 2000-04-17
ZA982365B (en) 1998-09-23
WO1998042713A1 (fr) 1998-10-01
BR9808346A (pt) 2000-05-23
NO994527L (no) 1999-11-18
SK127699A3 (en) 2000-05-16
HUP0002335A3 (en) 2002-07-29
CN1251105A (zh) 2000-04-19
KR20000076282A (ko) 2000-12-26
CO4940417A1 (es) 2000-07-24
AU6924298A (en) 1998-10-20
NO994527D0 (no) 1999-09-17
EP0971929A1 (fr) 2000-01-19
HUP0002335A2 (hu) 2001-05-28
JP2001518099A (ja) 2001-10-09
BG103684A (en) 2000-06-30
NZ337566A (en) 2000-09-29
FR2761072B1 (fr) 1999-04-23
CA2282320A1 (en) 1998-10-01
FR2761072A1 (fr) 1998-09-25

Similar Documents

Publication Publication Date Title
NZ314419A (en) Substituted 2,4-aryl-3-hydroxyalkyl pyridines; preparation and medicaments
SI1019358T1 (en) 3,3-diarylpropylamines , their use and preparation
HUP0102549A3 (en) Platinum complex, its preparation and therapeutic application
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
CY2291B1 (en) 1H-pyridoa3,4-buindole-4-carboxamide derivatives preparation and application thereof in therapeutics
IL118485A (en) 5,6-dihydro-9H-pyrazolo¬3,4-c¾-1,2,4-triazolo¬4,3-a¾ pyridines and pharmaceutical compositions containing them
HK1028027A1 (en) 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b)-indole-1-acetamide derivatives, their preparation and their application in therapy
IL131645A (en) Pyrimido ¬1,2-a¾indole derivatives and their preparation
IL131254A0 (en) 2,3-Dihydrofuro ¬3,2-b¾ pyridin preparation and application thereof in therapy
IL113332A0 (en) Boronic peptide derivatives, preparation and therapeutic application thereof
AU734696B2 (en) Novel carboxylic acid derivatives, their preparation and use in treating cancer
IL107133A0 (en) Piperidine derivatives,their preparation and their application in therapy
HUP0201762A3 (en) Platinum complex, its preparation and therapeutic application
IL101617A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their application in therapy
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
ZA892841B (en) Benzothiazepin-4-one derivative,their preparation and their application in therapy
ZA982369B (en) Dihydropyrazino[1,2-a]indol-1-one derivatives their preparation and their use in therapy
HUP0102409A3 (en) Pyrimidin-aminomethhyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
ZA977767B (en) Benzylamine derivatives, their preparation and their application in therapeutics.
ZA904290B (en) 1-phenyl-1,4-dihydro-3-amino-4-oxopyridazine derivatives,their preparation and their application in therapy
ZA976828B (en) 6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine-3-acetic acid derivatives, their preparation and their application in therapy.
ZA953749B (en) 5,6-dihydro-4H-thieno[3,4-c] pyrroie derivatives their preparation and their therapeutic application
HK1015813A1 (en) Reactive dyes, their preparation and use thereof
SI0991650T1 (en) Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy